https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Men with obesity tend to be insulin resistant and often have low-normal testosterone concentrations. We conducted a clinical trial aimed to evaluate potential therapeutic strategies for low testosterone in men with obesity. We did a 1-year, parallel, randomized, double-blind, placebo-controlled trial, where we evaluated the independent and combined effects of metformin and testosterone in 106 men with obesity, aged 18-50years, who had low levels of testosterone and no diabetes mellitus. The primary outcome was change in insulin
Like
Comment
Share
